Journal
KIDNEY INTERNATIONAL
Volume 79, Issue 1, Pages 33-45Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2010.337
Keywords
aminoglycoside antibiotics; gentamicin; nephrotoxicity; pathophysiology; prevention
Categories
Funding
- Instituto de Salud Carlos III [016/2006, PI081900]
- Junta de Castilla y Leon (Excellence Group) [GR-100]
- Ministerio de Ciencia y Tecnologia [BFU2004-00285/BFI, SAF2007-63893]
Ask authors/readers for more resources
Nephrotoxicity is one of the most important side effects and therapeutical limitations of aminoglycoside antibiotics, especially gentamicin. Despite rigorous patient monitoring, nephrotoxicity appears in 10-25% of therapeutic courses. Traditionally, aminoglycoside nephrotoxicity has been considered to result mainly from tubular damage. Both lethal and sub-lethal alterations in tubular cells handicap reabsorption and, in severe cases, may lead to a significant tubular obstruction. However, a reduced glomerular filtration is necessary to explain the symptoms of the disease. Reduced filtration is not solely the result of tubular obstruction and tubular malfunction, resulting in tubuloglomerular feedback activation; renal vasoconstriction and mesangial contraction are also crucial to fully explain aminoglycoside nephrotoxicity. This review critically presents an integrative view on the interactions of tubular, glomerular, and vascular effects of gentamicin, in the context of the most recent information available. Moreover, it discusses therapeutic perspectives for prevention of aminoglycoside nephrotoxicity derived from the pathophysiological knowledge. Kidney International (2011) 79, 33-45; doi: 10.1038/ki.2010.337; published online 22 September 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available